Muscle Wasting Disorders Market Estimated to Expand at a Robust CAGR by 2025

 Muscle wasting is also known as muscle atrophy, which causes weakening of muscle tissue. Muscle atrophy causes a substantial decrease in muscle strength and ability of muscle movement. Muscle wasting in healthy a person is caused by lack of physical exercise. However, people affected by certain diseases such as AIDS, cancer, cachexia, sarcopenia, etc. can also experience muscle atrophy. Increase in prevalence of chronic disorders such as cachexia and sarcopenia and rise in geriatric population across the globe are major factors driving the global muscle wasting disorders market. Sarcopenia is the progressive loss of skeletal muscle, which takes place with aging.  Most individuals begin to lose muscle mass after the age of thirty. Sarcopenia affects approximately 30% of individuals who are above the age of sixty and more than 50% of individuals above eighty years of age. The weakness associated with sarcopenia dramatically increases the risk of accidents due to falls in older adults. It has been reported that nearly half of all accidental deaths among individuals over sixty-five years is due to falls. Other metabolic conditions such as insulin resistance, type 2 diabetes, and obesity can also give rise to sarcopenia. The health care expenditure on sarcopenia stands at approximately US$ 900 per person in a year. Thus, a rise in awareness about sarcopenia and related disorders is expected to drive demand for muscle wasting disorder therapeutics during the forecast period.

Request For Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39452

Increase in research & development activities by leading pharmaceutical companies, surge in prevalence of chronic diseases such as cancer and spinal muscular atrophy, and a rise in the geriatric population globally are major factors propelling the muscle wasting disorders market. Moreover, increased government funding for research and  rise in cancer awareness programs and patient support programs in developing countries are anticipated to boost the muscle wasting disorders market in the near future. A number of drugs in the pipeline for the treatment of spinal muscular atrophy have received orphan drug designation in the U.S. as well as Europe due to strong government support. This is projected to help the spinal muscular atrophy market expand rapidly, while encouraging pharmaceutical companies to invest in the development of novel therapeutics for the treatment of SMA. However, stringent regulatory requirements and high cost of drug development are anticipated to restrain the market.

The global muscle wasting disorders market can be segmented based on treatment type, disease indication, end-user, and geography. In terms of treatment type, the global muscle wasting disorders market can be classified into drug treatment, surgical method, and other treatments. Promising clinical pipeline and upcoming regulatory approvals are the major factors contributing to a rapid expansionof the drug treatment segment. For instance, several drugs for cancer cachexia that are currently under clinical trial have shown promising effects. These drugs include ghrelin mimetics, selective cox-2 inhibitors, thalidomide, insulin, olanzapine, and oxandrolone.

Request For Custom Research @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=39452

Based on disease indication, the global muscle wasting disorders market can be divided into cancer, chronic heart failure, kidney disease, sarcopenia, and others. The cancer disease indication segment is anticipated to constitute a major share of the market in the near future due to the rise in incidence of cancer worldwide. Rise in cancer-afflicted population is anticipated to be one of the key drivers of the muscle wasting disorders market. According to a Centers for Disease Control and Prevention (CDC) report in 2014, the number of cancer patients diagnosed in the U.S. stood at approximately twenty-one million. This number is expected to reach 25.4 million by the end of 2024. Moreover, the National Cancer Institute also states that approximately 20% to 40% of cancer patients die due to cachexia.

Pre Book A Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=39452&ltype=S

Based on geography, the global muscle wasting disorders market can be split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Established industrial infrastructure and increase in product development of muscle wasting drugs across verticals are likely to propel the muscle wasting disorders market in North America during the forecast period. Moreover, increase in demand for early diagnosis and rise in government regulations for quality assurance and efficacy of muscle wasting disorders drugs are anticipated to boost the market. The muscle wasting disorders market in Asia Pacific is estimated to expand at a rapid pace during the forecast period owing to a rise in the geriatric population, large patient pool, increase in concerns regarding basic health care, and rise in infrastructure standards in the region.

Some of the major players in the global muscle wasting disorders market are Biogen, Pfizer, BioMarin Pharmaceutical Inc, Cellular Biomedicine Group, Inc., Ionis Pharmaceuticals, Marathon Pharmaceuticals LLC, Mitsubishi Tanabe Pharma, Morphosys AG, Novartis AG, Sarepta Therapeutics, and Teijin Pharma.

More Trending Reports by Transparency Market Research

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Comments

Post a Comment

Popular posts from this blog

MRI Guided Neurosurgical Ablation Market Prospects and Growth Assessment

  Global MRI Guided Neurosurgical Ablation Market: Overview Globally, the expenditure on healthcare services has grown dramatically in both developed and developing regions because of technological advancements and efforts made to provide better quality of treatment to patients. Growing awareness about the minimally invasive surgeries has increased the demand for MRI guided neurosurgical ablation. The demand for MRI guided neurosurgical procedure is emerging from countries like Germany, the U.S., U.K., and Australia as people in these countries have the capability to afford this procedure. In 2017, the Oxford University published a study stating that 5.57 per 100,000 individuals are suffering from brain cancer across the globe. Thus, the growing prevalence of brain cancer has increased the demand for MRI guided neurosurgical ablation, as it is mainly used for treating brain cancer. The global MRI guided neurosurgical ablation market is classified on the basis of product type and end
Read more

Dermal Allograft Market: Value Chain, Stakeholder Analysis and Trends

  Dermal Allograft Market: Snapshot The dermal allograft market may invite considerable growth during the assessment period of 2020-2030. The rising awareness about the various benefits of dermal allograft may bring immense growth prospects for the dermal allograft market. A dermal allograft is a method used to cure or enhance the inner layer of the skin called the dermis. It boosts the wound healing process by releasing cytokines. Grafts are used extensively for a plethora of soft tissue applications. Hence, this aspect may invite substantial growth prospects for the dermal allograft market during the forecast period of 2020-2030. Request For Brochure @  https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=79724 On the basis of type, the dermal allograft market can be classified into acellular allograft and cellular allograft. This technique is used for treating vascular ulcers, burn injury, diabetic foot ulcers, acute wounds, and others. It is used across c
Read more

Top 10 key Players In Bipolar Electrosurgery : Outlook, Growth and Share Estimation Analysis | Covidien plc (Medtronic), Ethicon, Inc., B. Braun Melsungen AG, Olympus Corporation

  Electrosurgery is a minimally invasive surgical procedure in which radiofrequency (RF) alternating current is used to increase intracellular temperature. Increase in the tissue temperature leads to cell desiccation or vaporization. This results into cutting or coagulation of tissue. Electrodessication is primarily used to block lumen-containing structures, or to remove big unwanted tissue such as soft tissue neoplasms. Protein coagulation is done to achieve hemostasis as well. The term electrosurgery is often used interchangeably with electrocautery which is not correct and it is important to know that both the procedures are different. Electrocautery depends on the use of direct current (unidirectional electron flow) in which the destruction or denaturation of tissue is achieved by passive heat transfer instrument and the current does not enter patient’s body. Electrosurgery uses alternating current including the patient’s body in the electrical circuit. This circuit consists of a s
Read more